1. Belantamab mafodotin induces immunogenic cell death within 24 h post‐administration in newly diagnosed multiple myeloma patients. Issue 3 (30th December 2022) Authors: Kostopoulos, Ioannis V.; Kakalis, Antonis; Birmpilis, Anastasios; Angelis, Nikolaos; Orologas‐Stavrou, Nikolaos; Rousakis, Pantelis; Panteli, Chrysanthi; Gavriatopoulou, Maria; Kastritis, Efstathios; Dimopoulos, Meletios‐Athanasios; Tsitsilonis, Ourania; Terpos, Evangelos Journal: American journal of hematology Issue: Volume 98:Issue 3(2023) Page Start: E65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and More. Issue 3 (30th September 2022) Authors: Kostopoulos, Ioannis V.; Ntanasis-Stathopoulos, Ioannis; Rousakis, Pantelis; Eleutherakis-Papaiakovou, Evangelos; Panteli, Chrysanthi; Malandrakis, Panagiotis; Angelis, Nikolaos; Kanellias, Nikolaos; Orologas-Stavrou, Nikolaos; Papanota, Aristina; Fotiou, Despina; Migkou, Magdalini; Gavriatopoulo... Journal: Journal of clinical oncology Issue: Volume 41:Issue 3(2023) Page Start: 708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Wnt and Src signals converge on YAP‐TEAD to drive intestinal regeneration. (5th May 2021) Authors: Guillermin, Oriane; Angelis, Nikolaos; Sidor, Clara M; Ridgway, Rachel; Baulies, Anna; Kucharska, Anna; Antas, Pedro; Rose, Melissa R; Cordero, Julia; Sansom, Owen; Li, Vivian S W; Thompson, Barry J Journal: EMBO journal Issue: Volume 40:Number 13(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗